Incyte (STU:ICY) 3-Year Book Growth Rate

: 24.80% (As of Dec. 2023)

View and export this data going back to 1993. Start your Free Trial

Incyte's Book Value per Share for the quarter that ended in Dec. 2023 was €21.22.

During the past 12 months, Incyte's average Book Value per Share Growth Rate was 17.90% per year. During the past 3 years, the average Book Value per Share Growth Rate was 24.80% per year. During the past 5 years, the average Book Value per Share Growth Rate was 20.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Incyte was 114.30% per year. The lowest was -113.90% per year. And the median was 21.70% per year.

Competitive Comparison

For the Biotechnology subindustry, Incyte's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Incyte 3-Year Book Growth Rate Distribution

For the Biotechnology industry and Healthcare sector, Incyte's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Incyte's 3-Year Book Growth Rate falls into.

Incyte 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Incyte (STU:ICY) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Incyte 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Incyte's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Incyte (STU:ICY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Incyte Corp (STU:ICY) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

INCY:USA 1INCY:Italy ICY:Germany I1NC34:Brazil

Address

1801 Augustine Cut-Off, Wilmington, DE, USA, 19803

Website

https://www.incyte.com

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.

Incyte (STU:ICY) Headlines

No Headlines